許諾付き医学雑誌データセット

{
  "article_id": "MED-J-2024-001278",
  "meta": {
    "title": "中国2型糖尿病防治指南（2024年版）— 药物治疗更新要点",
    "journal": "中华糖尿病杂志",
    "year": 2024,
    "volume": 16,
    "issue": 2,
    "article_type": "指南与共识"
  },
  "classification": {
    "department_l1": "内分泌科",
    "department_l2": "糖尿病",
    "disease_code": "E11.9",
    "article_type": "指南"
  },
  "content": {
    "abstract": "本文对2024年版中国2型糖尿病防治指南中药物治疗部分的更新要点进行解读，重点介绍新型降糖药物的推荐地位变化、联合用药策略优化及特殊人群用药指导。",
    "key_recommendations": [
      "HbA1c控制目标个体化：一般人群<7.0%，老年患者可放宽至7.5%-8.0%",
      "合并ASCVD或CKD患者优先选用SGLT-2i或GLP-1RA",
      "起始联合治疗适用于HbA1c≥7.5%的新诊断患者"
    ]
  },
  "images": [
    {
      "img_id": "FIG-001",
      "type": "流程图",
      "caption": "图1 2型糖尿病药物治疗路径图（2024版）"
    }
  ]
}

{
  "article_id": "MED-J-2023-008923",
  "meta": {
    "title": "肝脏局灶性病变的CT与MRI鉴别诊断",
    "journal": "临床放射学杂志",
    "year": 2023,
    "volume": 42,
    "issue": 11,
    "article_type": "综述"
  },
  "classification": {
    "department_l1": "影像科",
    "department_l2": "腹部影像",
    "disease_code": "K76.8",
    "article_type": "综述"
  },
  "content": {
    "abstract": "肝脏局灶性病变的影像学鉴别诊断是临床工作中的重点和难点。本文系统回顾了常见肝脏局灶性病变的CT和MRI表现特征，包括肝囊肿、血管瘤、局灶性结节增生、肝腺瘤及肝细胞癌等。",
    "differential_diagnosis": {
      "hemangioma": "CT平扫低密度，增强动脉期周边结节状强化，门静脉期及延迟期间心性充填。MRI T2WI呈明显高信号（灯泡征）。",
      "hcc": "CT增强呈快进快出模式。MRI T2WI呈轻-中度高信号，DWI扩散受限。",
      "fnh": "CT增强动脉期明显均匀强化（除中央瘢痕），门静脉期及延迟期等或略高密度。MRI肝胆期呈等或高信号。"
    }
  },
  "images": [
    {
      "img_id": "FIG-001",
      "type": "CT影像",
      "caption": "图1 肝血管瘤：A.CT平扫；B.动脉期；C.门静脉期；D.延迟期"
    },
    {
      "img_id": "FIG-002",
      "type": "MRI影像",
      "caption": "图2 肝细胞癌：A.T1WI；B.T2WI；C.DWI；D.增强动脉期"
    }
  ]
}